AeroVanc: Phase Ib data

Top-line data from 6 non-MRSA infected CF patients in the Phase Ib portion of an open-label, Australian Phase Ia/Ib trial showed that single doses of 32 and 80 mg AeroVanc were well tolerated. Savara ...